IP waiver for COVID vaccines misses the mark in vaccinating the world

Medicines Australia

14 June 2022 - Vaccinating the world remains a priority and proposals to weaken the intellectual property for COVID-19 vaccines are unnecessary, as this will not increase vaccination rates around the world.

This week, discussions at the WTO Ministerial Conference in Geneva, to introduce an intellectual property waiver – known as the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver – in the “Quad compromise”, takes precious attention away from more effective actions needed to increase vaccinations in our poorest nations.

Read Medicines Australia press release

Michael Wonder

Posted by:

Michael Wonder